Evidence map›Paper›PMID 38164753›Full record

ReviewHypertension (Dallas, Tex. : 1979)2024

Recent Advances in Understanding Peripheral and Gut Immune Cell-Mediated Salt-Sensitive Hypertension and Nephropathy.

Mohammad Saleem, Sepiso K Masenga, Jeanne A Ishimwe, Mert Demirci, Taseer Ahmad, Sydney Jamison, Claude F Albritton, Naome Mwesigwa, Alexandria Porcia Haynes, Jalyn White and 6 more

Open access · greenAbstract readReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Aging and sex differences in salt sensitivity of blood pressure.Clinical science (London, England : 1979) · 2025
    Review
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 4 countries.

Mohammad SaleemDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0000-0001-8091-8361
Sepiso K MasengaMulungushi University, School of Medicine and Health Sciences, HAND Research Group, Livingstone, Zambia (S.K.M.).ORCID 0000-0003-4376-5831
Jeanne A IshimweDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).
Mert DemirciDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0000-0003-3683-8238
Taseer AhmadDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0000-0003-4545-9598
Sydney JamisonDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0000-0003-2128-6303
Claude F AlbrittonDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0000-0002-6891-8737
Naome MwesigwaDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).
Alexandria Porcia HaynesDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).
Jalyn WhiteDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).
Kit NeikirkDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN (K.N., Z.V., A.H.).ORCID 0000-0003-0994-0333
Zer VueDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN (K.N., Z.V., A.H.).ORCID 0000-0002-3502-8906
Antentor HintonDepartment of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN (K.N., Z.V., A.H.).ORCID 0000-0002-7730-952X
Suha ArshadDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0009-0009-5663-3206
Selam DestaDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).
Annet KiraboDivision of Clinical Pharmacology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN (M.S., J.A.I., M.D., T.A., S.J., C.F.A., N.M., A.P.H., J.W., S.A., S.D., A.K.).ORCID 0000-0001-8580-9359
Vanderbilt University Medical Center · USVanderbilt University · USMeharry Medical College · USAnna Needs Neuroblastoma Answers · USBiology of Infection · FRMulungushi University · ZMSpelman College · USUniversity of Sargodha · PK

Funding

ENaC regulation and its role in blood pressure homeostasisR01HL147818 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Annet Kirabo, Thomas R Kleyman · 2019 to 2026
$4.6M
Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunctionR01HL157584 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET, SHIBAO, CYNDYA ADRIANA · 2021 to 2024
$3.0M
Immune Mechanisms of Salt-Sensitive hypertensionR01HL144941 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET · 2021 to 2025
$3.0M
Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney DiseaseR01DK135764 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI VALENTINA KON, Annet Kirabo · 2023 to 2026
$2.9M
Salt taste sensitivity, genetics and salt sensitivity of blood pressure in HIVR21TW012635 · FIC · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KIRABO, ANNET, MASENGA, SEPISO KENIAS · 2023 to 2024
$385k
American Heart Association-American Stroke Association AHA_23CDA1053072FIC NIH HHS R21 TW012635NHLBI NIH HHS R01 HL144941NHLBI NIH HHS R01 HL147818NHLBI NIH HHS R01 HL157584NIDDK NIH HHS R01 DK135764
6 · The paper itself

Abstract

Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide. Approximately 50% of hypertensive and 25% of normotensive people exhibit salt sensitivity of blood pressure, which is an independent risk factor for cardiovascular disease. Human and animal studies demonstrate that the immune system plays an important role in the etiology and pathogenesis of salt sensitivity of blood pressure, kidney damage, and vascular diseases. Antigen-presenting and adaptive immune cells are implicated in salt-sensitive hypertension and salt-induced renal and vascular injury. Elevated sodium activates antigen-presenting cells to release proinflammatory cytokines including IL (interleukin) 6, tumor necrosis factor-α, IL-1β, and accumulate isolevuglandin-protein adducts. In turn, these activate T cells release prohypertensive cytokines including IL-17A. Moreover, high-salt intake is associated with gut dysbiosis, leading to inflammation, oxidative stress, and blood pressure elevation but the mechanistic contribution to salt-sensitivity of blood pressure is not clearly understood. Here, we discuss recent advances in research investigating the cause, potential biomarkers, and therapeutic targets for salt-sensitive hypertension as they pertain to the gut microbiome, immunity, and inflammation.

Indexed as

HypertensionKidney DiseasesAnimalsBlood PressureCytokinesHumansInflammationInterleukin-6Sodium ChlorideSodium Chloride, DietaryCytokinesInterleukin-6Sodium ChlorideSodium Chloride, Dietarybiomarkerscardiovascular diseaseschemokinesinflammationoxidative stress

Identifiers

PMID38164753
PMCPMC10922672
OpenAlexW4390502162

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.